Maltacine C1b
| Internal ID | ed644c04-0653-478d-9b25-2f3277946db5 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides |
| IUPAC Name | 3-[12-(4-aminobutyl)-27-[[2-[[5-amino-5-oxo-2-[[(2S)-pyrrolidine-2-carbonyl]amino]pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-butan-2-yl-29-hydroxy-18-(1-hydroxyethyl)-6,15-bis[(4-hydroxyphenyl)methyl]-9-methyl-2,5,8,11,14,17,20,23,26-nonaoxo-24-propan-2-yl-1-oxa-4,7,10,13,16,19,22,25-octazacyclotriacont-21-yl]propanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C71H102N14O21/c1-7-37(4)58-71(105)106-35-46(90)34-54(81-66(100)51(31-40-13-19-43(87)20-14-40)80-63(97)49(25-27-55(73)91)77-61(95)47-12-10-30-74-47)68(102)83-57(36(2)3)69(103)78-50(26-28-56(92)93)64(98)85-59(39(6)86)70(104)82-52(32-41-15-21-44(88)22-16-41)65(99)76-48(11-8-9-29-72)62(96)75-38(5)60(94)79-53(67(101)84-58)33-42-17-23-45(89)24-18-42/h13-24,36-39,46-54,57-59,74,86-90H,7-12,25-35,72H2,1-6H3,(H2,73,91)(H,75,96)(H,76,99)(H,77,95)(H,78,103)(H,79,94)(H,80,97)(H,81,100)(H,82,104)(H,83,102)(H,84,101)(H,85,98)(H,92,93)/t37?,38?,39?,46?,47-,48?,49?,50?,51?,52?,53?,54?,57?,58?,59?/m0/s1 |
| InChI Key | BJDUCJXOROULFC-JMPPWOQRSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C71H102N14O21 |
| Molecular Weight | 1487.60 g/mol |
| Exact Mass | 1486.73439632 g/mol |
| Topological Polar Surface Area (TPSA) | 566.00 Ų |
| XlogP | -1.70 |
| Atomic LogP (AlogP) | -3.41 |
| H-Bond Acceptor | 22 |
| H-Bond Donor | 20 |
| Rotatable Bonds | 26 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.6525 | 65.25% |
| Caco-2 | - | 0.8637 | 86.37% |
| Blood Brain Barrier | - | 0.9750 | 97.50% |
| Human oral bioavailability | - | 0.6000 | 60.00% |
| Subcellular localzation | Nucleus | 0.3767 | 37.67% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8272 | 82.72% |
| OATP1B3 inhibitior | + | 0.9341 | 93.41% |
| MATE1 inhibitior | - | 0.9200 | 92.00% |
| OCT2 inhibitior | - | 0.9000 | 90.00% |
| BSEP inhibitior | + | 0.9401 | 94.01% |
| P-glycoprotein inhibitior | + | 0.7419 | 74.19% |
| P-glycoprotein substrate | + | 0.8904 | 89.04% |
| CYP3A4 substrate | + | 0.7453 | 74.53% |
| CYP2C9 substrate | - | 0.7952 | 79.52% |
| CYP2D6 substrate | - | 0.7947 | 79.47% |
| CYP3A4 inhibition | - | 0.6490 | 64.90% |
| CYP2C9 inhibition | - | 0.9168 | 91.68% |
| CYP2C19 inhibition | - | 0.8778 | 87.78% |
| CYP2D6 inhibition | - | 0.8716 | 87.16% |
| CYP1A2 inhibition | - | 0.9335 | 93.35% |
| CYP2C8 inhibition | + | 0.7862 | 78.62% |
| CYP inhibitory promiscuity | - | 0.8809 | 88.09% |
| UGT catelyzed | + | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.8100 | 81.00% |
| Carcinogenicity (trinary) | Non-required | 0.6065 | 60.65% |
| Eye corrosion | - | 0.9893 | 98.93% |
| Eye irritation | - | 0.8958 | 89.58% |
| Skin irritation | - | 0.7852 | 78.52% |
| Skin corrosion | - | 0.9318 | 93.18% |
| Ames mutagenesis | - | 0.7437 | 74.37% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7088 | 70.88% |
| Micronuclear | + | 0.7700 | 77.00% |
| Hepatotoxicity | - | 0.5500 | 55.00% |
| skin sensitisation | - | 0.8757 | 87.57% |
| Respiratory toxicity | + | 0.8556 | 85.56% |
| Reproductive toxicity | + | 0.9484 | 94.84% |
| Mitochondrial toxicity | + | 0.8875 | 88.75% |
| Nephrotoxicity | - | 0.7568 | 75.68% |
| Acute Oral Toxicity (c) | III | 0.6659 | 66.59% |
| Estrogen receptor binding | + | 0.5983 | 59.83% |
| Androgen receptor binding | + | 0.7662 | 76.62% |
| Thyroid receptor binding | + | 0.6827 | 68.27% |
| Glucocorticoid receptor binding | + | 0.7838 | 78.38% |
| Aromatase binding | + | 0.7377 | 73.77% |
| PPAR gamma | + | 0.7727 | 77.27% |
| Honey bee toxicity | - | 0.6842 | 68.42% |
| Biodegradation | - | 0.8250 | 82.50% |
| Crustacea aquatic toxicity | - | 0.5800 | 58.00% |
| Fish aquatic toxicity | + | 0.7676 | 76.76% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL3837 | P07711 | Cathepsin L | 99.92% | 96.61% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 99.86% | 93.10% |
| CHEMBL2581 | P07339 | Cathepsin D | 99.82% | 98.95% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 99.40% | 83.82% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 99.25% | 97.09% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.65% | 96.09% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 97.95% | 94.45% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 97.84% | 97.23% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 97.34% | 91.11% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 97.27% | 90.08% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 96.90% | 95.00% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 96.80% | 90.20% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 96.78% | 99.17% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 96.40% | 97.64% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 95.32% | 100.00% |
| CHEMBL206 | P03372 | Estrogen receptor alpha | 94.99% | 97.64% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 94.57% | 85.14% |
| CHEMBL242 | Q92731 | Estrogen receptor beta | 94.52% | 98.35% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 94.45% | 97.14% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 94.20% | 96.47% |
| CHEMBL236 | P41143 | Delta opioid receptor | 94.08% | 99.35% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 93.76% | 94.45% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 93.71% | 93.56% |
| CHEMBL1293287 | P14735 | Insulin-degrading enzyme | 93.65% | 88.10% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 93.20% | 96.67% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 92.91% | 95.38% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 92.43% | 95.89% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 92.35% | 90.71% |
| CHEMBL1801 | P00747 | Plasminogen | 91.81% | 92.44% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 91.78% | 100.00% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 91.76% | 93.00% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 91.19% | 98.05% |
| CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 90.73% | 91.71% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 90.64% | 82.69% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 90.50% | 95.50% |
| CHEMBL3880 | P07900 | Heat shock protein HSP 90-alpha | 89.75% | 96.21% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 89.14% | 91.19% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 89.11% | 98.94% |
| CHEMBL1907589 | P17787 | Neuronal acetylcholine receptor; alpha4/beta2 | 89.10% | 94.55% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 88.80% | 88.56% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 88.25% | 95.89% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 88.11% | 96.11% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 87.49% | 95.56% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 87.18% | 89.50% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 86.75% | 85.00% |
| CHEMBL226 | P30542 | Adenosine A1 receptor | 86.61% | 95.93% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 86.50% | 96.90% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 85.73% | 97.25% |
| CHEMBL3713062 | P10646 | Tissue factor pathway inhibitor | 85.60% | 97.33% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 85.37% | 100.00% |
| CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 84.45% | 95.50% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 83.55% | 96.33% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 83.31% | 96.00% |
| CHEMBL2821 | P00748 | Coagulation factor XII | 83.28% | 96.21% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 82.92% | 94.75% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 82.56% | 92.88% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 82.49% | 82.38% |
| CHEMBL4581 | P52732 | Kinesin-like protein 1 | 82.44% | 93.18% |
| CHEMBL1949 | P62937 | Cyclophilin A | 82.31% | 98.57% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 82.19% | 98.33% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 82.15% | 100.00% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 82.00% | 96.00% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 81.81% | 97.21% |
| CHEMBL4633 | P22001 | Voltage-gated potassium channel subunit Kv1.3 | 81.46% | 100.00% |
| CHEMBL4198 | P98170 | Inhibitor of apoptosis protein 3 | 80.68% | 97.79% |
| CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 80.06% | 92.32% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139588189 |
| LOTUS | LTS0059091 |
| wikiData | Q105100759 |